InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,099.96
(
1.02%
)
US TECH 100
17,244.80
(
1.57%
)
Dow Jones
38,239.66
(
0.40%
)
Brent Oil
88.17
(
0.00%
)
Bitcoin
63,884.18
(
0.75%
)

Replies to post #6817 on Capricor Therapeutics Inc (CAPR)

Replies to #6817 on Capricor Therapeutics Inc (CAPR)

mick

08/25/20 9:56 AM

#6819 RE: FOODINI #6817

$CAPR Capricor Therapeutics Announces U.S. FDA Acceptance of its IND Application for a Phase 2 Clinical Trial of CAP-1002 in Patients with COVID-19
GlobeNewswire
Capricor Therapeutics
,GlobeNewswire•August 25, 2020

https://finance.yahoo.com/news/capricor-therapeutics-announces-u-fda-131500614.html